FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

16683002: Progesterone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
28249012 Progesterone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
477894010 PRG - Progesterone en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Progesterone Is a Ovarian hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Progesterone derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Pregnane (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Steroid hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Ovarian hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Progesterone receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Substance with progesterone receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing drospirenone and ethinylestradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely megestrol acetate 125 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing drospirenone and estradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 400mg/mL injection suspension 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel 75 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norgestrel 75 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 150mg/mL injection suspension 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 400mg/mL injection suspension 2.5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone 150mg/ml injection 1ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 400mg/mL injection suspension 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental progestogen poisoning Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Intentional progestogen poisoning Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progestogen poisoning of undetermined intent Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Poisoning caused by progestogen (disorder) Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing estradiol and levonorgestrel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogesterone hexanoate 250mg/1mL oily injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogestérone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogesterone hexanoate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing gestonorone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 100mg vaginal insert The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing progesterone in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone-containing product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to progesterone Causative agent (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Free progesterone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone-releasing vaginal ring The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 200 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 200 mg oral capsule Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 200 mg oral capsule Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule Has precise active ingredient False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 50 milligram/1 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 50 milligram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing progesterone in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only progesterone in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone only product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 50 mg/mL solution for injection Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 50 mg/mL solution for injection Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 40 mg/g vaginal gel Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 40 mg/g vaginal gel Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 80 mg/g vaginal gel Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 80 mg/g vaginal gel Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 100 mg vaginal tablet Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 100 mg vaginal tablet Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Autoimmune progesterone dermatitis Causative agent (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 416.667 microgram/hour prolonged-release vaginal ring Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone 416.667 microgram/hour prolonged-release vaginal ring Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) Has precise active ingredient True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely progesterone 200 milligram/1 each conventional release vaginal capsule (clinical drug) Has basis of strength substance (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Serum progesterone measurement Component True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Saliva 17alpha-hydroxyprogesterone measurement (procedure) Component True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 2

Start Previous Page 3 of 3


This concept is not in any reference sets

Back to Start